论文部分内容阅读
目的:探讨重症脑血管病临床治疗中施以早期肠内营养支持疗法的效果及对免疫功能的影响。方法:收治重症脑血管病患者65例,随机分组。A组31例给予鼻饲支持疗法,B组34例给予早期肠内营养支持疗法。结果:A组有效率低于B组(P<0.05);B组CD4/CD8、Ig G、CD4、Ig M值、CD8以及Ig A改善水平优于A组(P<0.05)。结论:早期肠内营养支持疗法可行性偏高,建议对重症脑血管病患者使用早期肠内营养支持疗法,改善其免疫功能,实现良好的重症脑血管病病情转归,进而改善其预后。
Objective: To investigate the effect of early enteral nutrition support therapy in clinical treatment of severe cerebrovascular disease and its effect on immune function. Methods: 65 patients with severe cerebrovascular disease were randomly divided into groups. A group of 31 cases given nasogastric support therapy, B group 34 cases given early enteral nutrition support therapy. Results: The effective rate in group A was lower than that in group B (P <0.05). The improvement of CD4 / CD8, Ig G, CD4, IgM, CD8 and IgA in group B was better than that in group A (P <0.05). Conclusions: Early enteral nutrition support therapy is highly feasible. It is suggested that early enteral nutrition support therapy should be used in patients with severe cerebrovascular disease to improve its immune function and to achieve good outcome of severe cerebrovascular disease and to improve its prognosis.